Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726259 | SCV000701322 | pathogenic | not provided | 2017-05-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000595361 | SCV000952927 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2023-12-15 | criteria provided, single submitter | clinical testing | This sequence change affects an acceptor splice site in intron 23 of the CAPN3 gene. While this variant is not anticipated to result in nonsense mediated decay, it likely alters RNA splicing and results in a disrupted protein product. This variant is present in population databases (no rsID available, gnomAD 0.007%). Disruption of this splice site has been observed in individual(s) with clinical features of autosomal recessive limb-girdle muscular dystrophy (PMID: 26886200; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 288971). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV000726259 | SCV002025055 | likely pathogenic | not provided | 2019-03-18 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003475916 | SCV004211516 | likely pathogenic | Muscular dystrophy, limb-girdle, autosomal dominant 4 | 2024-03-20 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000595361 | SCV000798808 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2A | 2019-07-12 | no assertion criteria provided | clinical testing |